Morgan Stanley’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-252,730
Closed -$13.9M 8212
2022
Q2
$13.9M Buy
252,730
+157,574
+166% +$8.67M ﹤0.01% 2691
2022
Q1
$3.05M Buy
95,156
+84,950
+832% +$2.72M ﹤0.01% 4187
2021
Q4
$222K Buy
10,206
+10,173
+30,827% +$221K ﹤0.01% 6012
2021
Q3
$1K Buy
33
+23
+230% +$697 ﹤0.01% 7895
2021
Q2
$0 Hold
10
﹤0.01% 7889
2021
Q1
$0 Sell
10
-992
-99% ﹤0.01% 7629
2020
Q4
$16K Sell
1,002
-9,248
-90% -$148K ﹤0.01% 6510
2020
Q3
$109K Buy
10,250
+9,874
+2,626% +$105K ﹤0.01% 5392
2020
Q2
$4K Sell
376
-155
-29% -$1.65K ﹤0.01% 6366
2020
Q1
$5K Buy
531
+175
+49% +$1.65K ﹤0.01% 6240
2019
Q4
$5K Buy
356
+345
+3,136% +$4.85K ﹤0.01% 6405
2019
Q3
$0 Sell
11
-50
-82% ﹤0.01% 6845
2019
Q2
$1K Sell
61
-21,260
-100% -$349K ﹤0.01% 6598
2019
Q1
$1.46M Sell
21,321
-1,576
-7% -$108K ﹤0.01% 3849
2018
Q4
$1.21M Sell
22,897
-1,916
-8% -$101K ﹤0.01% 4140
2018
Q3
$1.69M Buy
24,813
+2,518
+11% +$171K ﹤0.01% 4148
2018
Q2
$2.64M Buy
22,295
+14,780
+197% +$1.75M ﹤0.01% 3821
2018
Q1
$622K Buy
7,515
+7,465
+14,930% +$618K ﹤0.01% 4870
2017
Q4
$7K Buy
+50
New +$7K ﹤0.01% 6292
2017
Q3
Sell
-1
Closed 6661
2017
Q2
$0 Sell
1
-60
-98% ﹤0.01% 6691
2017
Q1
$4K Sell
61
-402
-87% -$26.4K ﹤0.01% 6397
2016
Q4
$28K Buy
463
+377
+438% +$22.8K ﹤0.01% 5913
2016
Q3
$6K Sell
86
-688
-89% -$48K ﹤0.01% 6214
2016
Q2
$62K Buy
774
+499
+181% +$40K ﹤0.01% 5451
2016
Q1
$73K Buy
275
+174
+172% +$46.2K ﹤0.01% 5457
2015
Q4
$61K Sell
101
-2,089
-95% -$1.26M ﹤0.01% 5633
2015
Q3
$1.8M Buy
+2,190
New +$1.8M ﹤0.01% 3613